Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $1.55 billion. The enterprise value is $982.93 million.
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RLAY has 173.32 million shares outstanding. The number of shares has increased by 28.69% in one year.
| Current Share Class | 173.32M |
| Shares Outstanding | 173.32M |
| Shares Change (YoY) | +28.69% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 2.25% |
| Owned by Institutions (%) | 56.24% |
| Float | 98.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 181.61 |
| Forward PS | n/a |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 117.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.14, with a Debt / Equity ratio of 0.05.
| Current Ratio | 19.14 |
| Quick Ratio | 18.29 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.14% and return on invested capital (ROIC) is -26.54%.
| Return on Equity (ROE) | -41.14% |
| Return on Assets (ROA) | -25.37% |
| Return on Invested Capital (ROIC) | -26.54% |
| Return on Capital Employed (ROCE) | -50.96% |
| Weighted Average Cost of Capital (WACC) | 12.90% |
| Revenue Per Employee | $44,441 |
| Profits Per Employee | -$1.58M |
| Employee Count | 188 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.22% in the last 52 weeks. The beta is 1.62, so RLAY's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +86.22% |
| 50-Day Moving Average | 8.01 |
| 200-Day Moving Average | 5.24 |
| Relative Strength Index (RSI) | 61.00 |
| Average Volume (20 Days) | 2,454,065 |
Short Selling Information
The latest short interest is 22.38 million, so 12.91% of the outstanding shares have been sold short.
| Short Interest | 22.38M |
| Short Previous Month | 22.23M |
| Short % of Shares Out | 12.91% |
| Short % of Float | 22.75% |
| Short Ratio (days to cover) | 10.46 |
Income Statement
In the last 12 months, RLAY had revenue of $8.36 million and -$297.59 million in losses. Loss per share was -$1.75.
| Revenue | 8.36M |
| Gross Profit | -259.24M |
| Operating Income | -324.79M |
| Pretax Income | -297.59M |
| Net Income | -297.59M |
| EBITDA | -320.50M |
| EBIT | -324.79M |
| Loss Per Share | -$1.75 |
Full Income StatementBalance Sheet
The company has $596.43 million in cash and $33.33 million in debt, with a net cash position of $563.10 million or $3.25 per share.
| Cash & Cash Equivalents | 596.43M |
| Total Debt | 33.33M |
| Net Cash | 563.10M |
| Net Cash Per Share | $3.25 |
| Equity (Book Value) | 607.71M |
| Book Value Per Share | 3.52 |
| Working Capital | 591.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$248.46 million and capital expenditures -$409,000, giving a free cash flow of -$248.87 million.
| Operating Cash Flow | -248.46M |
| Capital Expenditures | -409,000 |
| Free Cash Flow | -248.87M |
| FCF Per Share | -$1.44 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -3,887.34% |
| Pretax Margin | -3,561.86% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.69% |
| Shareholder Yield | -28.69% |
| Earnings Yield | -19.25% |
| FCF Yield | -16.10% |
Analyst Forecast
The average price target for RLAY is $15.75, which is 76.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.75 |
| Price Target Difference | 76.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 78.77% |
| EPS Growth Forecast (5Y) | -10.14% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RLAY has an Altman Z-Score of 1.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.95 |
| Piotroski F-Score | 3 |
